<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-bayesian-methodology-guidance-webinar-october-2026</loc>
    <lastmod>2026-08-25T11:38:27+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Schedules Bayesian Guidance Webinar For Regulatory Teams</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/32d73393-66d6-4474-8ff0-48f63b576e0e.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-dscsa-waiver-exception-exemption-small-business-dispenser-2026</loc>
    <lastmod>2026-08-25T12:02:47+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Updates DSCSA Waiver Framework With Small Business Exemption</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/a33e2305-baf7-44cb-9887-33fb77e5e669.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-drug-supply-chain-security-framework-dscsa-compliance</loc>
    <lastmod>2026-08-25T11:38:30+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Reinforces Multi-Layer Drug Supply Chain Security Framework</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/6c47a5e4-d08a-40e1-86f7-b8d500af78e1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/vitruvias-therapeutics-recalls-thyroid-tablets-usp-30mg-superpotency-lot-504950</loc>
    <lastmod>2026-08-25T12:15:16+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>Vitruvias Recalls Thyroid Tablets 30 mg Lot Over Superpotency</news:title>
      <news:keywords>Vitruvias</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/c2e6541f-198f-40df-9a9d-b4481c54f9dc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/capricor-therapeutics-deramiocel-bla-review-extension-november-2026</loc>
    <lastmod>2026-08-25T12:11:54+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>Capricor's Deramiocel Gets November 2026 FDA Review Date</news:title>
      <news:keywords>Capricor Therapeutics</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/cbaf4cb0-7164-4486-8444-f3881c5a67e6.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-ectd-40-esg-cloud-modernization-pdufa-vii</loc>
    <lastmod>2026-08-25T12:13:12+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Advances eCTD 4.0 and ESG Cloud Modernization Under PDUFA VII</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/b227f490-a4a5-45e6-90ef-ddb2f1b0c218.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-rdea-meeting-package-requirements-rare-disease-novel-endpoints</loc>
    <lastmod>2026-08-25T12:18:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Sets RDEA Meeting Requirements for Rare Disease Endpoints</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/f1b2ea3b-ae32-4c1b-95ad-4fc7a1e60733.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fda-updates-counterfeit-ozempic-warning-glp1-supply-chain-risks-2025</loc>
    <lastmod>2026-08-25T12:17:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-25T00:00:00+05:30</news:publication_date>
      <news:title>FDA Updates Ozempic Counterfeit Warning Amid GLP-1 Risks</news:title>
      <news:keywords>FDA</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/41ec52d9-3313-431c-9e90-a8817957fd0c/b0f48762-683b-448d-ba8d-8d02ba57a78a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/bristol-myers-squibb-chai-discovery-ai-antibody-discovery-deal</loc>
    <lastmod>2026-08-25T12:33:43+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>Bristol Myers Squibb Signs AI Deal With Chai To Accelerate Drug Discovery</news:title>
      <news:keywords>Bristol Myers Squibb Signs AI Deal With Chai</news:keywords>
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bb451ba8-dcd5-4615-8242-a128fbd36c90/0f6f45f3-0eba-41fb-b402-44f80ba5d626.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/fibrobiologics-appoints-leigh-steinberg-board-director-longevity-pipeline</loc>
    <lastmod>2026-08-24T22:27:53+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>FibroBiologics Appoints Leigh Steinberg as Board Director to Advance Longevity Pipeline</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bb451ba8-dcd5-4615-8242-a128fbd36c90/2d439140-3440-4923-8e57-98deceb4573d.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/lexicon-pharmaceuticals-secures-third-10m-milestone-novo-nordisk-lx9851-phase-1</loc>
    <lastmod>2026-08-24T22:28:50+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>Lexicon Secures Third $10M Milestone from Novo Nordisk for Phase 1 Dosing</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bb451ba8-dcd5-4615-8242-a128fbd36c90/d9ef8b7b-306a-4c16-b53a-137cd5639323.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/scisparc-neurothera-clearmind-mdma-pea-patent-fda-psychedelic-guidance-ptsd</loc>
    <lastmod>2026-08-24T22:30:25+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>SciSparc-Clearmind Collaboration Wins U.S. MDMA-PEA Patent</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bb451ba8-dcd5-4615-8242-a128fbd36c90/0162dde8-69a6-4c07-a083-189843f96e8d.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/capricor-therapeutics-pdufa-extension-deramiocel-bla-major-amendment</loc>
    <lastmod>2026-08-24T22:31:31+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>FDA Extends PDUFA Review for Capricor’s Deramiocel</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/bb451ba8-dcd5-4615-8242-a128fbd36c90/b5d1c598-f915-4bba-a02b-dca9aaf1c1ab.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/insmed-mhlw-approval-brensocatib-ncfb-japan</loc>
    <lastmod>2026-08-24T22:32:55+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>Insmed Gains MHLW Approval In Non-Cystic Fibrosis Bronchiectasis Across Three Major Markets</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/86117b8c-6c90-4240-9dc2-019ba3885547/ba94e0e0-19c0-43dd-b464-cd573ce9c7fc.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ani-pharmaceuticals-appoints-henry-gosebruch-board-rare-disease</loc>
    <lastmod>2026-08-24T22:24:56+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>ANI Pharmaceuticals Appoints Henry Gosebruch to Board as Rare Disease Pivot Accelerates</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/86117b8c-6c90-4240-9dc2-019ba3885547/6282b64d-55e1-4fac-b340-48ccc557b983.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/johnson-johnson-eu-approval-teclistamab-daratumumab-relapsed-refractory-myeloma</loc>
    <lastmod>2026-08-24T22:35:03+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>Johnson &amp; Johnson Wins EU Approval for Teclistamab-Daratumumab Combo</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/86117b8c-6c90-4240-9dc2-019ba3885547/6f45c419-f075-49af-bcbe-d558d58ec75a.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://www.pharmanow.live/latest-news/ptc-therapeutics-acquires-sangamo-st-920-fabry-gene-therapy-bankruptcy-auction</loc>
    <lastmod>2026-08-24T22:24:52+05:30</lastmod>
    <news:news>
      <news:publication>
        <news:name>Pharma Now</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-24T00:00:00+05:30</news:publication_date>
      <news:title>PTC Acquires Sangamo’s Fabry Gene Therapy for $111M</news:title>
      
    </news:news>
    
    <image:image>
      <image:loc>https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/86117b8c-6c90-4240-9dc2-019ba3885547/04516289-a42b-4155-8ddc-ebf429dd8e7b.png</image:loc>
    </image:image>
  </url>
</urlset>